ATE257009T1 - Verwendung einer verbindung zur herstellung eines medikaments zur behandlung von alopecia oder zur förderung des haarwuchses bei tieren - Google Patents

Verwendung einer verbindung zur herstellung eines medikaments zur behandlung von alopecia oder zur förderung des haarwuchses bei tieren

Info

Publication number
ATE257009T1
ATE257009T1 AT98925163T AT98925163T ATE257009T1 AT E257009 T1 ATE257009 T1 AT E257009T1 AT 98925163 T AT98925163 T AT 98925163T AT 98925163 T AT98925163 T AT 98925163T AT E257009 T1 ATE257009 T1 AT E257009T1
Authority
AT
Austria
Prior art keywords
hair growth
medication
animals
compound
producing
Prior art date
Application number
AT98925163T
Other languages
English (en)
Inventor
Gregory S Hamilton
Joseph P Steiner
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Application granted granted Critical
Publication of ATE257009T1 publication Critical patent/ATE257009T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98925163T 1998-06-03 1998-06-03 Verwendung einer verbindung zur herstellung eines medikaments zur behandlung von alopecia oder zur förderung des haarwuchses bei tieren ATE257009T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/011264 WO1999062491A1 (en) 1998-06-03 1998-06-03 Small molecule pipecolic acid derivative hair growth compositions and uses

Publications (1)

Publication Number Publication Date
ATE257009T1 true ATE257009T1 (de) 2004-01-15

Family

ID=22267207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925163T ATE257009T1 (de) 1998-06-03 1998-06-03 Verwendung einer verbindung zur herstellung eines medikaments zur behandlung von alopecia oder zur förderung des haarwuchses bei tieren

Country Status (8)

Country Link
EP (1) EP1083874B1 (de)
JP (1) JP2002516847A (de)
AT (1) ATE257009T1 (de)
AU (1) AU767155B2 (de)
CA (1) CA2333961A1 (de)
DE (1) DE69820911T2 (de)
ES (1) ES2209147T3 (de)
WO (1) WO1999062491A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
AU6060299A (en) * 1998-09-30 2000-04-17 Procter & Gamble Company, The Method of treating hair loss using ketoamides
KR20030043928A (ko) 2000-08-08 2003-06-02 바이오아미드 인코포레이티드 조직 조작된 모발용 지지체
US7597885B2 (en) 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
TW200800240A (en) 2005-11-22 2008-01-01 Aderans Res Inst Inc Hair follicle graft from tissue engineered skin
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters

Also Published As

Publication number Publication date
ES2209147T3 (es) 2004-06-16
DE69820911T2 (de) 2004-11-18
EP1083874A1 (de) 2001-03-21
AU7717698A (en) 1999-12-20
CA2333961A1 (en) 1999-12-09
AU767155B2 (en) 2003-10-30
EP1083874B1 (de) 2004-01-02
JP2002516847A (ja) 2002-06-11
DE69820911D1 (de) 2004-02-05
WO1999062491A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
ATE266397T1 (de) Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
ATE267822T1 (de) Verfahren zur herstellung von luteolin und luteolin-derivaten
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69934120D1 (de) Inhibitoren der proteasomalen aktivität zur stimulierung des haarwuchses
ATE241353T1 (de) Fumarsäurederivate zur behandlung der transplantatabstossung
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
DE69614014D1 (de) Mittel und kosmetisches Verfahren zur Haarausfallbehandlung
DE69109115D1 (de) Verfahren zur behandlung der alopezie.
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE513588T1 (de) Verwendung eines pyridindicarbosäurederivates oder eines salzes davon, zur stimulation oder anregung von keratinischen faserwachstum und/oder zur verhinderung von dessen verlust
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
EP1109548A4 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole
DE60315842D1 (de) Verwendung von hesperidin oder einem seiner derivate zur herstellung eines medikaments für die stimulierung der knochenbildung
DE69837564D1 (de) Azaheterozyklischederivate zur behandlung von haarausfall und neurologischer krankheiten
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
DE69820911D1 (de) Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
EP1046392A3 (de) Kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE3853884D1 (de) Kombination aus minoxidil und einer antiinflammatorischen substanz zur behandlung der alopezie.
ATE321589T1 (de) Verwendung einer zubereitung und ein kosmetisches verfahren zur verminderung und vorbeugung von beissender der haut
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1083874

Country of ref document: EP

REN Ceased due to non-payment of the annual fee